Litcius/Paper detail

Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

Olalla Lima, Adrián Sousa, R. Longueira-Suárez, A. Filgueira, C. Taboada-Martínez, C. Portela-Pino, Andrés Nodar, F. Vasallo-Vidal, Lucía Martínez-Lamas, Antonio Pérez‐Landeiro, Martin Rubianes, Martı́n Pérez-Rodrı́guez

2022European Journal of Clinical Microbiology & Infectious Diseases21 citationsDOI

Topics & Concepts

BacteremiaKlebsiella pneumoniaeInternal medicineCeftazidime/avibactamMedicineCeftazidimeRetrospective cohort studyLogistic regressionAntibioticsSurgeryMicrobiologyBiologyPseudomonas aeruginosaBacteriaEscherichia coliGeneBiochemistryGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance
Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae | Litcius